{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:30:02Z","timestamp":1758274202527,"version":"3.37.3"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:00:00Z","timestamp":1622332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["10-LABX-LERMIT"],"award-info":[{"award-number":["10-LABX-LERMIT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20150934719"],"award-info":[{"award-number":["DEQ20150934719"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise de rhumatologie"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The impact of treatment on the risk of lymphoma in patients with rheumatoid arthritis (RA) is unclear. Here, we aimed to assess if the risk of lymphoma differs according to the type of tumor necrosis factor inhibitor (TNFi), comparing monoclonal anti-TNF antibodies to the soluble TNF receptor. We used B cell activating factor belonging to the TNF family (BAFF)-transgenic (Tg) mice as a model of autoimmunity-associated lymphoma. Six-month-old BAFF-Tg mice were treated with TNFi for 12\u00a0months. Histological examination of the spleen, assessment of the cellular composition of the spleen by flow cytometry and assessment of B cell clonality were performed at euthanasia. Crude mortality and incidence of lymphoma were significantly higher in mice treated with monoclonal anti-TNF antibodies compared to both controls and mice treated with the soluble TNF receptor, even at a high dose. Flow cytometry analysis revealed decreased splenic macrophage infiltration in mice treated with monoclonal anti-TNF antibodies. Overall, this study demonstrates, for the first time, that a very prolonged treatment with monoclonal anti-TNF antibodies increase the risk of lymphoma in B cell-driven autoimmunity. These data suggest a closer monitoring for lymphoma development in patients suffering from B cell-driven autoimmune disease with long-term exposure to monoclonal anti-TNF antibodies.<\/jats:p>","DOI":"10.1111\/cei.13602","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T04:50:38Z","timestamp":1618635038000},"page":"169-181","source":"Crossref","is-referenced-by-count":4,"title":["Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-0733","authenticated-orcid":false,"given":"Gaetane","family":"Nocturne","sequence":"first","affiliation":[{"name":"Department of Rheumatology, FHU CARE, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"},{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bineta","family":"Ly","sequence":"additional","affiliation":[{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Paoletti","sequence":"additional","affiliation":[{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Pascaud","sequence":"additional","affiliation":[{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphaele","family":"Seror","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, FHU CARE, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"},{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Nicco","sequence":"additional","affiliation":[{"name":"Cochin Institute, INSERM, University Paris Descartes, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Mackay","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute in Brisbane QLD, Herston, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F B","family":"Vincent","sequence":"additional","affiliation":[{"name":"Rheumatology Research Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lazure","sequence":"additional","affiliation":[{"name":"Department of Pathology, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Ferlicot","sequence":"additional","affiliation":[{"name":"Department of Pathology, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Stimmer","sequence":"additional","affiliation":[{"name":"US27 Platform for Experimental Pathology, Molecular Imaging Research Center, INSERM-CEA, Fontenay-aux-Roses, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Pascal","sequence":"additional","affiliation":[{"name":"US27 Platform for Experimental Pathology, Molecular Imaging Research Center, INSERM-CEA, Fontenay-aux-Roses, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Roulland","sequence":"additional","affiliation":[{"name":"Aix Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Krzysiek","sequence":"additional","affiliation":[{"name":"Department of Immunology, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima","family":"Hacein-Bey","sequence":"additional","affiliation":[{"name":"Department of Immunology, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Batteux","sequence":"additional","affiliation":[{"name":"Cochin Institute, INSERM, University Paris Descartes, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, FHU CARE, AP-HP, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"},{"name":"INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,30]]},"reference":[{"key":"2021121100031479600_cei13602-bib-0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2021121100031479600_cei13602-bib-0002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021121100031479600_cei13602-bib-0003","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2021121100031479600_cei13602-bib-0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med"},{"issue":"9701","key":"2021121100031479600_cei13602-bib-0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"2021121100031479600_cei13602-bib-0006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0007","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/annrheumdis-2017-211623","article-title":"Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0008","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0009","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"2021121100031479600_cei13602-bib-0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0011","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bjd.15023","article-title":"Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry","volume":"176","author":"Zweegers","year":"2017","journal-title":"Br J Dermatol"},{"key":"2021121100031479600_cei13602-bib-0012","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0013","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2009.117762","article-title":"Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry","volume":"69","author":"Mariette","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0014","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/14397595.2016.1141740","article-title":"Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: a nationwide cohort study in Japan","volume":"26","author":"Harigai","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2021121100031479600_cei13602-bib-0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/annrheumdis-2016-209389","article-title":"Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0016","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"key":"2021121100031479600_cei13602-bib-0017","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"issue":"6781","key":"2021121100031479600_cei13602-bib-0018","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"Gross","year":"2000","journal-title":"Nature"},{"issue":"2","key":"2021121100031479600_cei13602-bib-0019","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.172.2.812","article-title":"TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma","volume":"172","author":"Batten","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"2021121100031479600_cei13602-bib-0020","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","article-title":"Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice","volume":"97","author":"Khare","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021121100031479600_cei13602-bib-0021","first-page":"282","article-title":"Identification of markers for imminent death in mice used in longevity and aging research","volume":"49","author":"Ray","year":"2010","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"2021121100031479600_cei13602-bib-0022","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2018-213403","article-title":"Methotrexate and BAFF interaction prevents immunization against TNF inhibitors","volume":"77","author":"Bitoun","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021121100031479600_cei13602-bib-0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09629350123139","article-title":"Establishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cells","volume":"10","author":"Shiau","year":"2001","journal-title":"Mediat Inflamm"},{"key":"2021121100031479600_cei13602-bib-0024","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1073\/pnas.91.7.2762","article-title":"Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis","volume":"91","author":"Williams","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"volume-title":"humira-epar-scientific-discussion_en.pdf","key":"2021121100031479600_cei13602-bib-0025"},{"key":"2021121100031479600_cei13602-bib-0026","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep"},{"key":"2021121100031479600_cei13602-bib-0027","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/rheumatology\/kep270","article-title":"Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients","volume":"48","author":"Aringer","year":"2009","journal-title":"Rheumatology"},{"key":"2021121100031479600_cei13602-bib-0028","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.berh.2016.02.009","article-title":"New biological therapies in Sj\u00f6gren's syndrome","volume":"29","author":"Nocturne","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2021121100031479600_cei13602-bib-0029","doi-asserted-by":"crossref","first-page":"465898","DOI":"10.1155\/2010\/465898","article-title":"Anti-TNF-\u03b1 therapies in systemic lupus erythematosus","volume":"2010","author":"Zhu","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"2021121100031479600_cei13602-bib-0030","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-\u03b1 in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021121100031479600_cei13602-bib-0031","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE-promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2021121100031479600_cei13602-bib-0032","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021121100031479600_cei13602-bib-0033","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-015-0516-6","article-title":"Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor \u03b1 inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study","volume":"17","author":"Smolen","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021121100031479600_cei13602-bib-0034","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"7","key":"2021121100031479600_cei13602-bib-0035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.187.7.1009","article-title":"B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion","volume":"187","author":"Fu","year":"1998","journal-title":"J Exp Med"},{"key":"2021121100031479600_cei13602-bib-0036","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1997.tb00965.x","article-title":"Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers","volume":"156","author":"Matsumoto","year":"1997","journal-title":"Immunol Rev"},{"issue":"5","key":"2021121100031479600_cei13602-bib-0037","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.4049\/jimmunol.164.5.2508","article-title":"Lymphotoxin-alpha-dependent spleen microenvironment supports the generation of memory B cells and is required for their subsequent antigen-induced activation","volume":"164","author":"Fu","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"2021121100031479600_cei13602-bib-0038","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood-2010-11-321265","article-title":"Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs","volume":"118","author":"Rehm","year":"2011","journal-title":"Blood"},{"key":"2021121100031479600_cei13602-bib-0039","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1982423","article-title":"Immune checkpoint inhibitors to treat malignant lymphomas","author":"Witkowska","year":"2018","journal-title":"J Immunol Res"},{"key":"2021121100031479600_cei13602-bib-0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2018.00288","article-title":"Microenvironment cell contribution to lymphoma immunity","volume":"8","author":"Kumar","year":"2018","journal-title":"Front Oncol"},{"key":"2021121100031479600_cei13602-bib-0041","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2017.02.001","article-title":"Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas","volume":"80","author":"Nocturne","year":"2017","journal-title":"J Autoimmun"},{"key":"2021121100031479600_cei13602-bib-0042","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1756-8722-4-50","article-title":"The four types of Tregs in malignant lymphomas","volume":"4","author":"Wang","year":"2011","journal-title":"J Hematol Oncol"},{"key":"2021121100031479600_cei13602-bib-0043","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.11702","article-title":"Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma","volume":"93","author":"Tzankov","year":"2008","journal-title":"Haematologica"},{"issue":"20","key":"2021121100031479600_cei13602-bib-0044","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","article-title":"Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"issue":"7","key":"2021121100031479600_cei13602-bib-0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J Exp Med"},{"key":"2021121100031479600_cei13602-bib-0046","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fonc.2018.00147","article-title":"The role of macrophage\/B-cell interactions in the pathophysiology of B-cell lymphomas","volume":"8","author":"Pham","year":"2018","journal-title":"Front Oncol"},{"issue":"18","key":"2021121100031479600_cei13602-bib-0047","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin's lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N Engl J Med"},{"key":"2021121100031479600_cei13602-bib-0048","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/j.gastro.2017.07.021","article-title":"Anti-tumor necrosis factor with a glyco-engineered Fc-region has increased efficacy in mice with colitis","volume":"153","author":"Bloemendaal","year":"2017","journal-title":"Gastroenterology"},{"key":"2021121100031479600_cei13602-bib-0049","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"2021121100031479600_cei13602-bib-0050","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.4049\/jimmunol.1900386","article-title":"Monocyte\/macrophage abnormalities specific to rheumatoid arthritis are linked to miR-155 and are differentially modulated by different TNF inhibitors","volume":"203","author":"Paoletti","year":"2019","journal-title":"J Immunol"},{"key":"2021121100031479600_cei13602-bib-0051","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13602","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/2\/169\/41591428\/cei13602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/2\/169\/41591428\/cei13602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:26Z","timestamp":1641054326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/205\/2\/169\/6431137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,30]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,30]]},"published-print":{"date-parts":[[2021,7,12]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13602","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"type":"print","value":"0009-9104"},{"type":"electronic","value":"1365-2249"}],"subject":[],"published-other":{"date-parts":[[2021,8]]},"published":{"date-parts":[[2021,5,30]]}}}